Toutes les études
Actif, mais pas en recrutementPHASE2INTERVENTIONNEL

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

This research study is about a new treatment called Povetacicept for adults (18-80 years old) who have generalized myasthenia gravis (gMG). This condition causes muscle weakness. In the study, some people will receive Povetacicept, while others will receive a placebo (a dummy treatment, like a sugar pill) to see if the new medicine works better. The main goals are to understand how Povetacicept affects the body, how well it's tolerated, and if it's safe. This is a 'Phase 2' study, which means it's an early stage of testing to get more information before potentially moving to larger studies.

En un coup d'œil

Statut
Actif, mais pas en recrutement
Phase
PHASE2
Sponsor
Vertex Pharmaceuticals Incorporated
Objectif d'inscription
34
Démarrer
13 May 2026
Achèvement estimé
02 Mar 2029

De quoi parle cette étude ?

This research is looking into a new medication called Povetacicept for people who have generalized myasthenia gravis, often shortened to gMG. Myasthenia gravis is a condition that causes muscle weakness throughout the body because the immune system mistakenly attacks healthy tissues.

The main aim of this study is to learn more about how Povetacicept works in the body. We want to understand what effects it has on the condition and if it's absorbed and used as expected. We also want to make sure the medication is safe for people to take and that it doesn't cause too many side effects.

This is a 'Phase 2' study. This means it's an important step after initial safety tests, but before very large studies are done. It helps researchers decide if the medication is promising enough to continue developing. Some participants will receive the new medicine, while others will receive a 'placebo' – a treatment that looks the same but contains no active medicine. This helps researchers fairly compare how well the new medicine works.

Points clés

  • This study is for adults with generalized myasthenia gravis (gMG).
  • It's testing a new medicine called Povetacicept against a dummy treatment (placebo).
  • The main goals are to check the medicine's safety and how it works in the body.
  • This is a Phase 2 study, an important step in testing new treatments.
  • Participation involves regular clinic visits for check-ups and medication.

Qui peut être éligible ?

To be part of this study, you need to be an adult between 18 and 80 years old and have been diagnosed with generalized myasthenia gravis. This means your muscle weakness affects different parts of your body. Your doctor will also need to confirm that your myasthenia gravis falls within certain levels of severity.

There are also some important reasons why you might not be able to join. For example, if you've had surgery on your thymus gland in the last six months, or if you've had certain types of cancer in the last five years, you wouldn't be able to take part. There are other specific health conditions or treatments that might also prevent someone from joining, which your study doctor will discuss with you.

Essentially, the study is designed for a specific group of people to make sure the results are clear and safe. Your doctor will carefully check all the details to see if this study is suitable for you.

Cet étude pourrait-elle vous convenir ?

Répondez à ces questions rapides pour voir si vous êtes éligible. Ceci est un guide uniquement — l'équipe de recherche prend la décision finale.

  1. Avez-vous entre 18 et 80 ans ?
  2. Have you been diagnosed with generalized myasthenia gravis?
  3. Have you had thymic surgery more than 6 months ago?
  4. Have you been free from cancer for the last 5 years?
  5. Êtes-vous capable d'assister à des rendez-vous d'étude réguliers ?
Répondez à chaque question pour voir votre résultat.

En quoi consiste la participation ?

If you decide to take part in this study, you would be assigned to either receive the new medicine, Povetacicept, or a placebo (a dummy treament). You wouldn't know which one you're getting, and neither would the study team, to keep the results fair. You would need to attend several appointments at the study clinic for check-ups, tests, and to receive your study medication. These appointments would involve things like physical exams, blood tests, and questions about how you're feeling and any changes in your muscle weakness. There would also be follow-up appointments after you finish taking the study medicine to make sure everything is okay. The total length of your involvement in the study would be explained to you in detail by the study team.

Risques et avantages potentiels

Taking part in this study might offer some potential benefits, such as receiving a new medicine for your condition that isn't yet widely available, or getting extra close medical monitoring. However, there's no guarantee that Povetacicept will help your condition, and there's a chance you could receive the placebo. There are also potential risks involved, including possible side effects from the medication. The study team will explain all the known risks and potential side effects to you before you decide. Remember, participation is completely voluntary, and you have the right to withdraw from the study at any time, for any reason, without it affecting your medical care.

Emplacements (31)

  • Tri Valley Neurology Medical Associates Inc.
    Code postal vérifié
    Mission Hills, United States
  • Neurology Offices
    Code postal vérifié
    Boca Raton, United States
  • SFM Clinical Reseach, LLC
    Code postal vérifié
    Boca Raton, United States
  • Homestead Associates in Research
    Code postal vérifié
    Homestead, United States
  • UF Health Jacksonville Respiratory Therapy (PFT and DLCO)
    Code postal vérifié
    Jacksonville, États-Unis
  • Y & L Advance Health Care, Inc D/B/A Elite Clinical Research - Neurology
    Code postal vérifié
    Miami, États-Unis
  • Quantix Research
    Code postal vérifié
    Miami, États-Unis
  • USF Carol and Frank Morsani Center for Advanced Healthcare
    Code postal vérifié
    Tampa, États-Unis
  • Patient Care Clinical Research, LLC
    Code postal vérifié
    Snellville, United States
  • Hawaii Pacific Neuroscience
    Code postal vérifié
    Honolulu, United States
  • HSHS Medical Group - St. Elizabeth's Hospital
    Code postal vérifié
    O'Fallon, United States
  • Las Vegas Neurology Center
    Code postal vérifié
    Las Vegas, United States

Questions fréquentes

What is 'generalized myasthenia gravis'?

It's a condition where your immune system mistakenly attacks your muscles, causing weakness that can affect many parts of your body.

What does a 'Phase 2 study' mean?

It's an early stage of testing for a new medicine. It helps researchers understand how safe it is and how well it works before larger studies.

Qu'est-ce qu'un 'placebo' ?

A placebo is a dummy treatment that looks like the real medicine but contains no active ingredients. It helps compare the new medicine fairly.

Will I get help with travel costs if I join?

You should ask the study team if they offer any help with travel or other expenses for attending appointments.

Que se passe-t-il si je change d'avis après avoir rejoint ?

Vous êtes libre de quitter l'étude à tout moment, pour n'importe quelle raison, sans que cela n'affecte vos soins médicaux habituels.

Comment en savoir plus

Parlez toujours à votre médecin généraliste ou spécialiste avant de décider de participer à une étude.

Discussion

Discussion communautaire

Propulsé par notre forum à community.patient.info. Veuillez être respectueux — ceci n'est pas un avis médical.